Use of N-Acetylcysteine in Psychiatric Conditions among Children and Adolescents: A Scoping Review
| Autor: | Muhammad Waqar Azeem, Afshan Naz Amray, Ahmed Waqas, Sadiq Naveed, Amna Mohyud Din Chaudhary |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
tourette syndrome
cannabis medicine.medical_specialty media_common.quotation_subject review n-actylecysteine autism Tourette syndrome law.invention Acetylcysteine 03 medical and health sciences 0302 clinical medicine Randomized controlled trial children law medicine Psychiatry media_common biology business.industry Clinical study design Addiction General Engineering biology.organism_classification medicine.disease trichotillomania 030227 psychiatry pediatric pathological onychophagia Autism Over-the-counter Cannabis addiction business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| Popis: | N-acetylcysteine (NAC) is a well-known antidote for acetaminophen toxicity and is easily available over the counter. It has antioxidant and anti-inflammatory properties and an established tolerance and safety profile. Owing to its neuroprotective effects, its clinical use has recently expanded to include the treatment of different psychiatric and non-psychiatric disorders. Although a number of randomized controlled trials have documented the clinical evidence for NAC, there are no reviews that summarize the evidence. The present scoping review summarizes the study designs, the patient characteristics, the evidence and the limitations in randomized controlled trials designed to explore the efficacy of NAC for psychiatric conditions in the pediatric population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|